JLP-2302

· Onconic Therapeutics Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JLP-2302, covering 2025-09-18 to 2025-09-18. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Study of JLP-2302 and JP-1366: PK and Safety in Healthy Volunteers [Phase 1]